文献速递血栓与止血造血干细胞移植与细胞治疗

孕激素通过调控肠道菌群介导妊娠期免疫性血小板减少症患者骨髓间充质干细胞损伤

Progesterone regulates gut microbiota mediating bone marrow mesenchymal stem cell injury in immune thrombocytopenia patients during pregnancy.
PubMed 文献 · J Thromb Haemost · 2025-01-03

本研究探讨妊娠期免疫性血小板减少症(PITP)患者骨髓间充质干细胞(BM-MSCs)的特征及其与代谢物和肠道菌群的关系。PITP患者BM-MSCs出现显著衰老、凋亡及免疫调节功能受损,孕激素是PITP患者最显著的特定代谢物,孕激素通过调控肠道菌群组成介导BM-MSCs损伤。干预肠道菌群可能成为PITP的新治疗方法。

要点

  • PITP患者BM-MSCs呈现显著衰老、凋亡及免疫调节功能受损。
  • 孕激素是PITP患者最显著的特定代谢物,并在体内介导MSC损伤。
  • 孕激素通过调控肠道菌群组成介导PITP中BM-MSCs损伤。

核心结论

  • PITP中BM-MSCs显著受损,与孕激素升高及孕激素调控的肠道菌群变化相关。
  • 干预肠道菌群可能成为PITP的新治疗方法。

研究设计与样本

  • 通过体外和体内实验检测BM-MSCs特征。
  • 采用非靶向代谢组学筛选代谢物,通过16S rDNA测序分析肠道菌群特征。
  • 建立PITP和粪菌移植(FMT)小鼠模型探究代谢物、肠道菌群与BM-MSCs的关联。

主要发现

  • PITP患者BM-MSCs具有显著衰老和凋亡,以及免疫调节功能受损。
  • 代谢组学分析表明孕激素是PITP患者最显著的特定代谢物。
  • 体内研究表明孕激素介导MSC损伤。
  • 肠道菌群和FMT实验进一步分析揭示孕激素通过调控PITP中肠道菌群组成介导BM-MSCs损伤。
  • FMT小鼠BM-MSCs的RNA测序分析显示细胞衰老和NOD样受体信号通路相关基因异常表达。

临床怎么用

  • 作者认为干预肠道菌群可能成为PITP的新治疗方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immune thrombocytopenia during pregnancy (PITP) is the most common cause of platelet reduction in early and mid-pregnancy. However, the pathogenesis of PITP is still unclear. OBJECTIVES: To determine the characteristics of bone marrow mesenchymal stem cells (BM-MSCs) in PITP patients and to explore the associations between metabolites, the gut microbiota, and BM-MSCs in PITP. METHODS: The characteristics of BM-MSCs were detected through in vitro and in vivo experiments. Nontargeted metabolomics was used to screen metabolites. The features of the gut microbiota were analyzed by 16S rDNA sequencing. PITP and fecal microbiota transplantation (FMT) mouse model were established to explore the associations between metabolites, gut microbiota, and BM-MSCs. RESULTS: BM-MSCs from PITP patients had significant senescence and apoptosis, as well as impaired immunoregulatory function. Metabolomic analysis indicated that progesterone was the most significant specific metabolite in PITP patients. In vivo studies showed that progesterone mediated MSC injury. Further analysis of the gut microbiota and FMT experiments revealed that progesterone mediated BM-MSCs injury by regulating the composition of the gut microbiota in PITP. RNA sequencing analysis of BM-MSCs from FMT mice revealed abnormal expression of genes related to cell aging and the NOD-like receptor signaling pathway. CONCLUSION: In conclusion, BM-MSCs in the PITP were significantly impaired, which was associated with increased progesterone and changes in the gut microbiota regulated by progesterone. Intervening with the gut microbiota may become a new treatment for PITP.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Chen Q, Liu F, Zhang G, et al. Progesterone regulates gut microbiota mediating bone marrow mesenchymal stem cell injury in immune thrombocytopenia patients during pregnancy. J Thromb Haemost. 2025. PMID: 39756658. doi:10.1016/j.jtha.2024.12.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。